Editorial
Rev Diabet Stud,
2006,
3(1):6-10 |
DOI 10.1900/RDS.2006.3.6 |
Costimulation and Pancreatic Autoimmunity: The PD-1/PD-L Conundrum
Deepak Yadav, Nora Sarvetnick
The Scripps Research Institute, Department of Immunology, 10446, North Torrey Pines Road, IMM-23, San Diego, California 92037, USA.
Address correspondence to: Deepak Yadav, e-mail: dyadav@scripps.edu.
Keywords: type 1 diabetes, costimulation, autoimmunity, PD-1, PD-L1, PD-L2
Abstract
T cell activation is a complex process that requires a multitude of interactions between antigen-presenting cells (APC) and T cells. The primary signal is provided via the binding of the antigen (Ag) presented by the major histocompatibility complex (MHC) on an APC and the T cell receptor (TCR). This signal determines the specificity of the immune response but it is not sufficient to mount an effective antigen-specific immune response; co-signals are additionally required for that purpose. These co-signals are costimulatory pathways that can be either positive or negative and consequently determine the nature of the immune response. The B7-1/2/CD28 costimulatory axis is one of the most extensively studied positive signaling pathways, and it has been shown that this signal leads to a robust T cell activation, proliferation and survival. In this article we discuss the recently described PD-1/PD-L1/PD-L2 costimulatory axis, whose role in pancreatic autoimmunity is only just becoming more deeply understood. The blockade or deficiency of PD-1 leads to an exacerbation of diabetes, signifying that the role of PD-1 is to provide negative signals to T cells. On the other hand, the PD-1 ligand, PD-L1, has been shown to provide both positive and negative signals. The prediction of the existence of a non-PD-1 receptor on T cells capable of transmitting positive signals further adds to the complex nature of this costimulatory pathway.
Fulltext:
HTML
, PDF
(231KB)
This article has been cited by other articles:
|
Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes
Prasad S, Xu D, Miller SD
Rev Diabet Stud 2012. 9(4):319-327
|
|
|
PD-1 antibody blocks therapeutic effects of T-regulatory cells in Cockroach antigen-induced allergic asthma
McGee HS, Yagita H, Shao Z, Agrawal DK
Am J Respir Cell Mol Biol 2009. Nov 9, epub ahead of print
|
|
|
Changes of B7 family costimulatory molecules and their receptors expression in children with asthma
Zu Y, Li C, Li D, Zheng Y, Li J
J Appl Clin Pediatr 2009. 24(4):271-273
|
|
|
Transplantation of NIT-1 cells expressing PD-L1 for treatment of streptozotocin-induced diabetes
Wen X, Zhu H, Li L, Li Y, Wang M, Liu J, Yang D, Liao W, Shen G
Transplantation 2008. 86(11):1596-1602
|
|
|